Resources for media and journalists.
The Private Sector Co-payment Mechanism (“Co-payment Mechanism”) is a financing model used by the Global Fund, to expand access to artemisinin-based combination therapies (ACTs), in the private sector. The mechanism is suitable for countries where the private retail sector is a major provider of health technologies for malaria case management. It is possible that over time, the Private Sector Co-payment Mechanism may be expanded to include co-financing of malaria rapid diagnostic tests (RDTs).
The Private Sector Co-payment Mechanism is based on the results of the
Independent Evaluation of the Affordable Medicines Facility-malaria (AMFm) Phase 1, which showed that: i) a combination of price negotiations; ii) a subsidy provided directly to manufacturers; and iii) large-scale mass communications; led to rapid and large, changes in price, availability, and market share of quality-assured ACTs.